Newsroom | 70919 results

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its mission to build Multimodal Foundation Models at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus has been building novel biological foundation models and agentic workflows by leveraging its more than 500 petabytes of rich, molecularly grounded data—more than 45 million total de-identified...

NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the “Foundation”) today announced $6 million in funding to support eight pioneering scientists advancing innovative ovarian cancer research across the United States. For more than a decade, the Foundation has advanced transformative cancer research through the Pershing Square Sohn Cancer Research Alliance (“PSSCRA”). Building on its longstanding commitment to cancer research and women’s health, the Foundation is now in the second year o...

CHILLICOTHE, Ohio--(BUSINESS WIRE)--Ohio-made nitrile gloves by USMGC earn TSA approval, supplied through CABVI's federal contract for security officer protection....

PRINCETON, N.J.--(BUSINESS WIRE)--BMS Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in.......

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC). At seven years, patients treated with LORBRENA had a 55% likelihood of re...

EDMONTON, Alberta--(BUSINESS WIRE)--Youth Science Canada presented the top awards at the 2026 Canada-Wide Science Fair (CWSF) on Thursday evening in Edmonton, Alta....

EDMONTON, Alberta--(BUSINESS WIRE)--Sciences jeunesse Canada a présenté les grands prix de l'Expo-sciences pancanadienne (ESPC) 2026 jeudi soir à Edmonton (Alb.), où 390 finalistes de partout au Canada ont présenté 344 projets et se sont disputé près de 2 millions de dollars en prix, dans le cadre du plus grand événement en STIM pour les jeunes au Canada. Faits saillants : Liam Desre, de Kingston (Ont.), a remporté le Prix du meilleur projet — Découverte pour avoir proposé un nouveau modèle de...

--(BUSINESS WIRE)--UnitedHealthcare is removing two-thirds of authorization requirements for members under age 18 by year’s end. This move is the latest in a series of initiatives to simplify the healthcare system for providers and patients. The company is eliminating prior authorizations for many diagnostic services, routine surgical procedures and specialty care services across pediatric subspecialties such as cardiology, neurology, pulmonology and orthopedics. UnitedHealthcare is also introd...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibitor, in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the first-line treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC) with KRAS G12C-mutation and e...

TORONTO--(BUSINESS WIRE)--Phoenix and Raven offer eligible Canadians Ozempic® at the same starting price at $124.99 as generic semaglutide....